Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Rewiring of sIgM-Mediated Intracellular Signaling through the CD180 Toll-like Receptor.

Porakishvili N, Vispute K, Steele AJ, Rajakaruna N, Kulikova N, Tsertsvadze T, Nathwani A, Damle RN, Clark EA, Rai KR, Chiorazzi N, Lydyard PM.

Mol Med. 2015 Apr;21(1):46-57. doi: 10.2119/molmed.2014.00265. Epub 2015 Jan 14.

2.

CD180 functions in activation, survival and cycling of B chronic lymphocytic leukaemia cells.

Porakishvili N, Memon A, Vispute K, Kulikova N, Clark EA, Rai KR, Nathwani A, Damle RN, Chiorazzi N, Lydyard PM.

Br J Haematol. 2011 May;153(4):486-98. doi: 10.1111/j.1365-2141.2011.08605.x. Epub 2011 Mar 28.

PMID:
21443749
3.

Long-term treatment of NZB mice with anti-CD4 results in wasting disease, lymphoid atrophy and chronic diarrhea.

Oliveira GG, Holton J, Lydyard PM.

Gut Microbes. 2010 Sep;1(5):345-355. Epub 2010 May 24.

4.

Patients with B cell chronic lymphocytic leukaemia have an expanded population of CD4 perforin expressing T cells enriched for human cytomegalovirus specificity and an effector-memory phenotype.

Walton JA, Lydyard PM, Nathwani A, Emery V, Akbar A, Glennie MJ, Porakishvili N.

Br J Haematol. 2010 Jan;148(2):274-84. doi: 10.1111/j.1365-2141.2009.07964.x. Epub 2009 Nov 4.

PMID:
19895614
5.

Selection of the alternative exon 1 from the cd5 gene down-regulates membrane level of the protein in B lymphocytes.

Garaud S, Le Dantec C, Berthou C, Lydyard PM, Youinou P, Renaudineau Y.

J Immunol. 2008 Aug 1;181(3):2010-8.

6.

Differential expression of CD 180 and IgM by B-cell chronic lymphocytic leukaemia cells using mutated and unmutated immunoglobulin VH genes.

Porakishvili N, Kulikova N, Jewell AP, Youinou PY, Yong K, Nathwani A, Heelan B, Duke V, Hamblin TJ, Wallace P, Ely P, Clark EA, Lydyard PM.

Br J Haematol. 2005 Nov;131(3):313-9.

PMID:
16225650
7.

B cell response to surface IgM cross-linking identifies different prognostic groups of B-chronic lymphocytic leukemia patients.

Nédellec S, Renaudineau Y, Bordron A, Berthou C, Porakishvili N, Lydyard PM, Pers JO, Youinou P.

J Immunol. 2005 Mar 15;174(6):3749-56.

8.

Role of B-cell antigen receptor-associated molecules and lipid rafts in CD5-induced apoptosis of B CLL cells.

Renaudineau Y, Nédellec S, Berthou C, Lydyard PM, Youinou P, Pers JO.

Leukemia. 2005 Feb;19(2):223-9.

PMID:
15618965
9.

Antibodies to mannose binding lectin in patients with systemic lupus erythematosus.

Mok MY, Jack DL, Lau CS, Fong DY, Turner MW, Isenberg DA, Lydyard PM.

Lupus. 2004;13(7):522-8.

PMID:
15352424
10.

Cytotoxic CD4+ T cells in patients with B cell chronic lymphocytic leukemia kill via a perforin-mediated pathway.

Porakishvili N, Kardava L, Jewell AP, Yong K, Glennie MJ, Akbar A, Lydyard PM.

Haematologica. 2004 Apr;89(4):435-43.

11.

T cell receptor usage in patients with non-progressing HIV infection.

Bodman-Smith MD, Williams I, Johnstone R, Boylston A, Lydyard PM, Zumla A.

Clin Exp Immunol. 2002 Oct;130(1):115-20.

12.
13.

Characterization of CD3+ CD4- CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers.

Anand A, Dean GS, Quereshi K, Isenberg DA, Lydyard PM.

Lupus. 2002;11(8):493-500.

PMID:
12220103
14.

The H2 haplotype regulates the distribution of B cells into B-1a, B-1b and B-2 subsets.

Pers JO, Jamin C, Lydyard PM, Charreire J, Youinou P.

Immunogenetics. 2002 Jun;54(3):208-11. Epub 2002 Apr 23.

PMID:
12073150
15.

B cells underpin lupus immunopathology.

Youinou P, Lydyard PM, Mageed RA.

Lupus. 2002;11(1):1-3. Review. No abstract available.

PMID:
11898912
16.

CD5-induced apoptosis of B cells in some patients with chronic lymphocytic leukemia.

Pers JO, Berthou C, Porakishvili N, Burdjanadze M, Le Calvez G, Abgrall JF, Lydyard PM, Youinou P, Jamin C.

Leukemia. 2002 Jan;16(1):44-52.

17.

Expansion of CD4+ T cells with a cytotoxic phenotype in patients with B-chronic lymphocytic leukaemia (B-CLL).

Porakishvili N, Roschupkina T, Kalber T, Jewell AP, Patterson K, Yong K, Lydyard PM.

Clin Exp Immunol. 2001 Oct;126(1):29-36.

18.

CD5+ B cells in nonorgan-specific autoimmune diseases: a fresh look.

Youinou P, Lydyard PM.

Lupus. 2001;10(8):523-5. Review. No abstract available.

PMID:
11530992
19.

Recent progress in the understanding of B-cell functions in autoimmunity.

Porakishvili N, Mageed R, Jamin C, Pers JO, Kulikova N, Renaudineau Y, Lydyard PM, Youinou P.

Scand J Immunol. 2001 Jul-Aug;54(1-2):30-8. Review.

21.

CD8+ T cells in human uterine endometrial lymphoid aggregates: evidence for accumulation of cells by trafficking.

Yeaman GR, Collins JE, Fanger MW, Wira CR, Lydyard PM.

Immunology. 2001 Apr;102(4):434-40. Erratum in: Immunology 2001 Jul;103(3):399.

22.

CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.

Youinou P, Pers JO, Jamin C, Lydyard PM.

Pathol Biol (Paris). 2000 Jul;48(6):574-6. Review.

PMID:
10965537
23.

Decreased expression of FcgammaRIII (CD16) by gammadelta T cells in patients with rheumatoid arthritis.

Bodman-Smith MD, Anand A, Durand V, Youinou PY, Lydyard PM.

Immunology. 2000 Apr;99(4):498-503.

24.
25.

Human monoclonal anti-phospholipid antibodies selectively bind to membrane phospholipid and beta2-glycoprotein I (beta2-GPI) on apoptotic cells.

Pittoni V, Ravirajan CT, Donohoe S, MacHin SJ, Lydyard PM, Isenberg DA.

Clin Exp Immunol. 2000 Mar;119(3):533-43.

26.

The effect on immunoglobulin glycosylation of altering in vivo production of immunoglobulin G.

Jeddi P, Keusch J, Lydyard PM, Bodman-Smith KB, Chesnutt MS, Wofsy D, Hirota H, Taga T, Delves PJ.

Immunology. 1999 Nov;98(3):475-80.

27.

Possible improved survival of patients with stage IV AJCC melanoma receiving SRL 172 immunotherapy: correlation with induction of increased levels of intracellular interleukin-2 in peripheral blood lymphocytes.

Maraveyas A, Baban B, Kennard D, Rook GA, Westby M, Grange JM, Lydyard P, Stanford JL, Jones M, Selby P, Dalgleish AG.

Ann Oncol. 1999 Jul;10(7):817-24.

PMID:
10470429
28.

B lymphocyte galactosyltransferase protein levels in normal individuals and in patients with rheumatoid arthritis.

Keusch J, Lydyard PM, Berger EG, Delves PJ.

Glycoconj J. 1998 Nov;15(11):1093-7.

PMID:
10386894
29.

CD5 expression in human B-cell populations.

Youinou P, Jamin C, Lydyard PM.

Immunol Today. 1999 Jul;20(7):312-6. Review.

PMID:
10379049
30.

The role of CD5-expressing B cells in health and disease (review).

Pers JO, Jamin C, Predine-Hug F, Lydyard P, Youinou P.

Int J Mol Med. 1999 Mar;3(3):239-45. Review.

PMID:
10028047
31.

CD5 B cells and B-cell malignancies.

Lydyard PM, Jewell AP, Jamin C, Youinou PY.

Curr Opin Hematol. 1999 Jan;6(1):30-6. Review.

PMID:
9915551
32.

Ligation of CD5 on resting B cells, but not on resting T cells, results in apoptosis.

Pers JO, Jamin C, Le Corre R, Lydyard PM, Youinou P.

Eur J Immunol. 1998 Dec;28(12):4170-6.

33.

Antibody recognition of epitopes on wild-type and mutant beta-(1-->4)-galactosyltransferase-1.

Keusch J, Panayotou G, Malissard M, Berger EG, Appert HE, Lydyard PM, Delves PJ.

Carbohydr Res. 1998 Nov;313(1):37-48.

PMID:
9861700
34.

The effect on IgG glycosylation of altering beta1, 4-galactosyltransferase-1 activity in B cells.

Keusch J, Lydyard PM, Delves PJ.

Glycobiology. 1998 Dec;8(12):1215-20.

PMID:
9858643
35.

Modulation of CD72 by ligation of B cell receptor complex molecules on CD5+ B cells.

Jamin C, Le Corre R, Pers JO, Dueymes M, Lydyard PM, Youinou P.

Int Immunol. 1997 Jul;9(7):1001-9.

PMID:
9237109
36.

The stability of lymphocytic beta 1,4-galactosyltransferase expression during pregnancy and lactation.

Jeddi PA, Keusch J, Lydyard PM, Delves PJ.

Scand J Immunol. 1997 Feb;45(2):145-50.

37.

Lack of NK cells in lupus patients with renal involvement.

Erkeller-Yuksel FM, Lydyard PM, Isenberg DA.

Lupus. 1997;6(9):708-12.

PMID:
9412985
38.

Diverse antigen specificity of erythrocyte-reactive monoclonal autoantibodies from NZB mice.

de Sá Oliveira GG, Izui S, Ravirajan CT, Mageed RA, Lydyard PM, Elson CJ, Barker RN.

Clin Exp Immunol. 1996 Aug;105(2):313-20.

39.

Agalactosyl IgG and beta-1,4-galactosyltransferase gene expression in rheumatoid arthritis patients and in the arthritis-prone MRL lpr/lpr mouse.

Jeddi PA, Bodman-Smith KB, Lund T, Lydyard PM, Mengle-Gaw L, Isenberg DA, Youinou P, Delves PJ.

Immunology. 1996 Apr;87(4):654-9.

40.

Differential expression of Fc receptors for IgG by monocytes and granulocytes from neonates and adults.

Maeda M, van Schie RC, Yüksel B, Greenough A, Fanger MW, Guyre PM, Lydyard PM.

Clin Exp Immunol. 1996 Feb;103(2):343-7.

41.

Anti-CD5 extends the proliferative response of human CD5+ B cells activated with anti-IgM and interleukin-2.

Jamin C, Le Corre R, Lydyard PM, Youinou P.

Eur J Immunol. 1996 Jan;26(1):57-62.

PMID:
8566084
42.

CD5+B cells: differential capping and modulation of IgM and CD5.

Jamin C, Lydyard PM, Le Corre R, Youinou PY.

Scand J Immunol. 1996 Jan;43(1):73-80.

PMID:
8560199
43.

Anti CD5 sustains the proliferative response of IgM-activated human CD5+ B cells.

Jamin C, Dueymes M, Lydyard PM, Youinou P.

Scand J Immunol. 1995 Aug;42(2):282-5.

PMID:
7543217
44.

Growth factors can protect B-chronic lymphocytic leukaemia cells against programmed cell death without stimulating proliferation.

Jewell AP, Lydyard PM, Worman CP, Giles FJ, Goldstone AH.

Leuk Lymphoma. 1995 Jun;18(1-2):159-62.

PMID:
8580819
45.

beta 1,4-Galactosyltransferase activity in B cells detected using a simple ELISA-based assay.

Keusch J, Lydyard PM, Isenberg DA, Delves PJ.

Glycobiology. 1995 Jun;5(4):365-700.

PMID:
7579790
46.
47.

Glycosylation of IgG during potentially arthritogenic lentiviral infections.

McCulloch J, Zhang YW, Dawson M, Harkiss GD, Peterhans E, Vogt HR, Lydyard PM, Rook GA.

Rheumatol Int. 1995;14(6):243-8.

PMID:
7597380
48.

Reduced galactosyltransferase mRNA levels are associated with the agalactosyl IgG found in arthritis-prone MRL-lpr/lpr strain mice.

Jeddi PA, Lund T, Bodman KB, Sumar N, Lydyard PM, Pouncey L, Heath LS, Kidd VJ, Delves PJ.

Immunology. 1994 Nov;83(3):484-8.

49.

The pathophysiology of rheumatoid arthritis.

Lydyard PM, Edwards JC.

Clin Exp Rheumatol. 1994 Nov-Dec;12 Suppl 11:S55-8. Review.

PMID:
7768054
50.

Selective expression of V beta families by T cells in the blood and salivary gland infiltrate of patients with primary Sjögren's syndrome.

Smith MD, Lamour A, Boylston A, Lancaster FC, Pennec YL, van Agthoven A, Rook GA, Roncin S, Lydyard PM, Youinou PY.

J Rheumatol. 1994 Oct;21(10):1832-7.

PMID:
7837146

Supplemental Content

Loading ...
Support Center